RICHARD BOTTOMS: Open Payments
NPI 1932508801 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,366 in 106 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,024 · 2025 $2,366
Food & beverage: $2,156Education: $210
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $516 |
| Janssen Biotech, Inc. | 10 | $363 |
| Novartis Pharmaceuticals Corporation | 14 | $312 |
| E.R. Squibb & Sons, L.L.C. | 9 | $248 |
| Galderma Laboratories, L.P. | 13 | $235 |
| Lilly USA, LLC | 13 | $149 |
| Regeneron Healthcare Solutions, Inc. | 4 | $106 |
| GENZYME CORPORATION | 3 | $78 |
| UCB, Inc. | 2 | $59 |
| Organogenesis Inc. | 2 | $53 |
Products named: RINVOQ, TREMFYA, Sotyktu, NEMLUVIO, COSENTYX, SKYRIZI, DUPIXENT, TALTZ.
Industry payments across MO — which companies pay providers there.
